Microbiome
Sequencing Services Market accounted for US$ 2056.34 million in 2020 and is
estimated to be US$ 12331.2 million by 2030 and is anticipated to register a
CAGR of 19.80%. The study of genetic material obtained directly from microbes
is referred to as microbiome sequencing. Microbiome sequencing uses many
approaches to collect human biodata in order to better understand sickness. It
is the investigation of bacteria found in the human gut with the objective of
better understanding human microbes and their function in health and disease.
Previously, traditional microbiological procedures were employed to examine an
individual's phenotype and genotype by obtaining samples from the skin, blood,
or stool. Tools like next-generation testing are being utilised to generate
human microbiome data as technology advances.
The report " Global Microbiome Sequencing Services
Market, By Technology (Sequencing by Ligation (SBL), Sequencing by Synthesis
(SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, and
Other Technologies), By Application (Gastrointestinal Diseases, Infectious
Diseases, CNS Diseases, Oncology, and Others), By End- User(Research and
Academic Institutes, Pharmaceutical and Biotechnology Companies, and Other End
Users), and By Region (North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa) - Trends, Analysis and Forecast till 2030”
Key Highlights:
·
June 1, 2020 – Mérieux
NutriSciences, a global leader in food safety and quality, has acquired
Chestnut Labs, a provider of value-added food safety solutions, from Dairy
Farmers of America.
·
3rd of February, 2020 – Mérieux
NutriSciences, a global leader in food safety and a market leader in
environmental testing in Italy, has announced the acquisition of C.P.G. Lab, an
Italian company.
·
May 18th, 2021 Mérieux
NutriSciences, a global leader in food safety, quality, and sustainability,
announced that it has acquired majority control of UCGS in Wei Nan (Shaanxi
Province).
·
23rd of October, 2020 –
ProDigest, an intestinal research company, and Bio Fortis, a contract research
organisation for Mérieux NutriSciences that specialises in nutrition, health,
and microbiota studies, have signed a global partnership to strengthen and
expand their international services. Their combined knowledge in
gastrointestinal transit, bioavailability, metabolism, immune modulation, and
efficacy of food compounds, functional ingredients, and medicines allows
customers to produce medications, pre- and probiotics, and food ingredients
more quickly and effectively.
Analyst View:
Surge in the genomic research and widening application
area of the microbiome sequencing which is the boosting factor for the growth
of the target market. The NIAID (National Institute of Allergy and Infectious
Diseases) microbiome sequencing program involves the study and analysis of
functional and structural specification, associated with concerned body sites
and host organisms. However, the ethical and legal issues related to genome and
microbiome sequencing which is the major restraining factor for the growth of
the global market. Furthermore, the lack of skilled technicians for the next
gene sequencing analysis which is another hampering factor for the growth of
the global market.
Before purchasing this report, request a sample or make an inquiry
by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3922
Key Market Insights from the report:
The Global Microbiome Sequencing Services Market
accounted for US$ 2056.34 million in 2020 and is estimated to be US$ 12331.2
million by 2030 and is anticipated to register a CAGR of 19.80%. The global
microbiome sequencing services market is segmented based on technology,
application, end-user, and region.
·
By Technology,
the Global Microbiome Sequencing Services Market is segmented into Sequencing
by Ligation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing,
Targeted Gene Sequencing, RNA Sequencing, and Other Technologies.
·
By
Application, the market is segmented in Gastrointestinal Diseases, Infectious
Diseases, CNS Diseases, Oncology, and Others.
·
By End-User,
the market is segmented in Research and Academic Institutes, Pharmaceutical and
Biotechnology Companies, and Other End Users.
·
By region, the
Global Microbiome Sequencing Services Market is segmented into North America,
Europe, Asia Pacific, Latin America, and Middle East & Africa. The market
in the Europe region accounts highest revenue share to the global microbiome
sequencing services market due to the growing incidence of cancer. North
America region is projected to register a high CAGR over the forecast period
owing to the growing trend of the NGS which helps to recover cancer and the
joint infections.
Competitive Landscape:
The key players operating the global surgical stapler market
involves Baseclear BV, Clinical Microbiomics A/S, Merieux Nutrisciences,
Jennewein Biotechnologie, Microbiome Insights Inc., Microbiome Therapeutics
LLC, MR DNA, Second Genome, Ubiome Inc., and Zymo Research Corp.
The market provides detailed information
regarding the industrial base, productivity, strengths, manufacturers, and
recent trends which will help companies enlarge the businesses and promote
financial growth. Furthermore, the report exhibits dynamic factors including
segments, sub-segments, regional marketplaces, competition, dominant key
players, and market forecasts. In addition, the market includes recent
collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks
across different regions impacting the market trajectory. Recent technological
advances and innovations influencing the global market are included in the
report.
